RTOG Mission

   Minimize

 

RTOG's Mission is to:

 
  • Improve the survival outcome and quality of life of adults with cancer through the conduct of high-quality clinical trials.

 

  • Evaluate new forms of radiotherapy delivery, including stereotactic radiotherapy, brachytherapy, 3-dimensional conformal radiotherapy (3-DCRT), and intensity-modulated radiotherapy (IMRT) in the context of clinical research.

 

  • Test new systemic therapies in conjunction with radiotherapy, including chemotherapeutic drugs, hormonal strategies, biologic agents, and new classes of cytostatic, cytotoxic, and targeted therapies.

 

  • Employ translational research strategies to identify patient subgroups at risk for failure with existing treatments and identify new approaches for these patients.